Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma

Acta Pharmacologica Sinica, Published online: 12 April 2024; doi:10.1038/s41401-024-01261-4Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma

Source: Acta Pharmacologica Sinica - April 12, 2024 Category: Drugs & Pharmacology Authors: Qi-yi Zhang Wen Ding Jian-shan Mo Shu-min Ou-yang Zi-you Lin Ke-ren Peng Guo-pin Liu Jin-jian Lu Pei-bin Yue Jin-ping Lei Yan-dong Wang Xiao-lei Zhang Source Type: research